Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -296.46 Million SEK | -55.09% |
| 2022 | -191.15 Million SEK | -14.72% |
| 2021 | -166.62 Million SEK | -24.03% |
| 2020 | -134.34 Million SEK | -17.59% |
| 2019 | -114.24 Million SEK | -30.26% |
| 2018 | -87.7 Million SEK | -92.68% |
| 2017 | -45.51 Million SEK | -203.91% |
| 2016 | -14.97 Million SEK | -101.75% |
| 2015 | -7.42 Million SEK | 17.14% |
| 2014 | -8.95 Million SEK | -455.23% |
| 2013 | -1.61 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -23.97 Million SEK | 1.03% |
| 2024 Q1 | -24.15 Million SEK | -3.21% |
| 2023 Q3 | -38.88 Million SEK | 78.99% |
| 2023 Q4 | -23.4 Million SEK | 39.81% |
| 2023 FY | -296.46 Million SEK | -55.09% |
| 2023 Q1 | -49.08 Million SEK | 3.91% |
| 2023 Q2 | -185.07 Million SEK | -277.07% |
| 2022 Q3 | -41.91 Million SEK | 17.47% |
| 2022 Q2 | -50.78 Million SEK | -7.22% |
| 2022 Q1 | -47.36 Million SEK | 6.9% |
| 2022 FY | -191.15 Million SEK | -14.72% |
| 2022 Q4 | -51.08 Million SEK | -21.86% |
| 2021 Q1 | -29.08 Million SEK | 23.69% |
| 2021 Q3 | -39.93 Million SEK | 14.54% |
| 2021 Q2 | -46.73 Million SEK | -60.69% |
| 2021 FY | -166.62 Million SEK | -24.03% |
| 2021 Q4 | -50.87 Million SEK | -27.39% |
| 2020 Q1 | -32.11 Million SEK | -8.56% |
| 2020 Q2 | 28.68 Million SEK | 189.33% |
| 2020 Q3 | -35.43 Million SEK | -223.52% |
| 2020 Q4 | -38.11 Million SEK | -7.56% |
| 2020 FY | -134.34 Million SEK | -17.59% |
| 2019 Q4 | -29.58 Million SEK | -5.93% |
| 2019 Q1 | -27.19 Million SEK | -5.59% |
| 2019 Q3 | -27.92 Million SEK | 5.47% |
| 2019 Q2 | -29.54 Million SEK | -8.62% |
| 2019 FY | -114.24 Million SEK | -30.26% |
| 2018 Q2 | -27.23 Million SEK | -56.71% |
| 2018 Q1 | -17.37 Million SEK | -13.11% |
| 2018 Q3 | -17.34 Million SEK | 36.31% |
| 2018 Q4 | -25.75 Million SEK | -48.51% |
| 2018 FY | -87.7 Million SEK | -92.68% |
| 2017 Q2 | -10.64 Million SEK | -35.26% |
| 2017 Q3 | -11.64 Million SEK | -9.36% |
| 2017 Q4 | -15.36 Million SEK | -31.97% |
| 2017 FY | -45.51 Million SEK | -203.91% |
| 2017 Q1 | -7.87 Million SEK | -42.39% |
| 2016 Q4 | -5.52 Million SEK | -36.54% |
| 2016 Q3 | -4.04 Million SEK | -36.43% |
| 2016 Q2 | -2.96 Million SEK | -21.85% |
| 2016 Q1 | -2.43 Million SEK | -35.72% |
| 2016 FY | -14.97 Million SEK | -101.75% |
| 2015 Q2 | -1.91 Million SEK | 0.0% |
| 2015 Q3 | -1.79 Million SEK | 6.46% |
| 2015 Q4 | -1.79 Million SEK | 0.0% |
| 2015 FY | -7.42 Million SEK | 17.14% |
| 2015 Q1 | -1.91 Million SEK | 37.36% |
| 2014 Q4 | -3.06 Million SEK | 0.0% |
| 2014 FY | -8.95 Million SEK | -455.23% |
| 2014 Q1 | -1.41 Million SEK | 0.0% |
| 2014 Q2 | -1.41 Million SEK | 0.0% |
| 2014 Q3 | -3.06 Million SEK | -115.93% |
| 2013 FY | -1.61 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -23769.565% |
| Arrayit Corporation | -3.62 Million USD | -8083.81% |
| Atlantic International Corp. | -5.73 Million USD | -5071.558% |
| Biocept, Inc. | -31.98 Million USD | -826.93% |
| Bioqual, Inc. | -19.63 Thousand USD | -1509524.198% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -38294.492% |
| DermTech, Inc. | -103.73 Million USD | -185.775% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 111.921% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | -1323.263% |
| iMD Companies, Inc. | -175.44 Thousand USD | -168875.069% |
| IDenta Corp. | -1499.00 USD | -19777084.79% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 10672.753% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 766344.508% |
| InVitro International | -25.33 Thousand USD | -1169875.137% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -4062.595% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -510052.808% |
| Medical Imaging Corp. | -819.48 Thousand USD | -36076.6% |
| NovelStem International Corp. | -3.52 Million USD | -8308.307% |
| Optigenex Inc. | 1.39 Million USD | 21415.253% |
| PharmChem, Inc. | 973.14 Thousand USD | 30564.051% |
| Proteome Sciences plc | -1.62 Million USD | -18188.711% |
| Response Genetics, Inc | -21.37 Million USD | -1286.818% |
| Rennova Health, Inc. | -1.4 Million USD | -20932.483% |
| RushNet, Inc. | -684.7 Thousand USD | -43197.478% |
| ScreenPro Security Inc. | -2.59 Million USD | -11335.612% |
| Stella Diagnostics Inc. | -11.42 Million USD | -2494.393% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -3726.89% |
| Todos Medical Ltd. | -9.74 Million USD | -2941.239% |